TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING

Clinical trials for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING explained in plain language.

Never miss a new study

Get alerted when new TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING trials appear

Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope to stop aggressive breast Cancer's return

Disease control Not yet recruiting

This large, late-stage trial aims to see if adding the drug pembrolizumab to standard follow-up treatment helps prevent cancer from coming back in people with early triple-negative breast cancer. It will enroll 1,000 patients whose cancer did not completely disappear after initia…

Matched conditions: TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING

Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING

Get alerted when new TRIPLE NEGATIVE BREAST CANCER (TNBC), EARLY SETTING trials appear

New hope to stop aggressive breast Cancer's return